Cholecystitis An inflammation of the gallbladder ... A chronic inflammatory disease of the gallbladder and liver, causing bile acid to accumulate, often resulting in debilitating itching. Primary ...
To clearly identify gallbladder inflammation, we only selected 993 patients in whom the pathology reports indicated the presence of cholecystitis. Of these, we first excluded the patients (n =197 ...
Background: The HELLP syndrome is a serious complication in pregnancy characterized by haemolysis, elevated liver enzymes and low platelet count occurring in 0.5 to 0.9% of all pregnancies and in ...
Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).
In this referral centre based study, inflammatory bowel disease associated with primary sclerosing cholangitis (PSC-IBD) was characterised by a high prevalence of pancolitis with rectal sparing and ...
Livdelzi (seladelpar) is a medicine that can treat primary biliary cholangitis (PBC) by reducing the amount of bile in your body. It does this by signaling the body to stop making bile acid.
Their presence sometimes indicates an underlying gallbladder issue, such as chronic cholecystitis, which is gallbladder inflammation. This inflammation occurs when the gallbladder does not empty ...
The primary outcome of interest was morbidity, with length of stays, conversions, operative time, failure rate, acute pancreatitis, cholangitis, wound infection ... groups had an advantage due to the ...